Consort Medical gets shareholder approval for sale of King Systems
Consort Medical will sell its King Systems division after receiving approval from shareholders.
Consort Medical will sell its King Systems division after receiving approval from shareholders.
The medical devices company said it will dispose of the manufacturer of anaesthesia and respiratory items for a consideration of $120m cash, plus an adjustment of approximately $5.0m for estimated working capital and net indebtedness at completion.
"Further to the announcement of its proposed disposal of King on December 20th, 2012, the company is therefore pleased to confirm that all conditions precedent have been satisfied and it has completed the proposed disposal," the group said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The initial consideration is subject to a post-completion adjustment for actual working capital and actual net indebtedness at completion.
Proceeds will be used to repay debts of the company.
Shares rose 2.73% to 678.50p at 14:44 Friday.
RD
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
UK-US trade deal announced: US cuts tariffs on UK car imports to 10%
Keir Starmer and Donald Trump have announced a UK-US trade deal, but the US president has refused to lift baseline tariffs on most UK goods. What does it mean for the UK?
-
How to use mid-caps to diversify from the US
Medium sized companies are overlooked by investors but could offer an attractive ‘sweet spot’. We consider the case for mid-caps amid market volatility.